The global spatial omics technologies market size was estimated to be USD 250.24 million in 2023 and is expected to reach at USD 774.75 million by 2033 with a CAGR of 10.82% during the forecast period 2024-2034. Increasing demand for single cell analysis, growing technological advancements in spatial omics, rising investment for the development of advanced platforms, surge in research & development activities, increasing demand for novel computational methods, growing prevalence of cancer, rising introduction of innovative products, and surge in collaborations within market players are some of the key factors boosting the market growth.
Surge in partnerships among market participants is predicted to boost the market growth during the forecast period. The market's rising financing and investment efforts for the advancement of spatial omics technology are a notable trend. For instance, in June 2023, Owkin's recent announcement of securing $50 million in funding and its collaboration with NanoString Technology and academic institutions in Europe and the United States serve as prime examples of this emerging trend. Their objective is to harness spatial omics technology to advance cancer research through the MOSAIC initiative (Multi Omics Spatial Atlas in Cancer). This endeavor will entail gathering and examining 7,000 tumor samples using spatial omics methods to uncover distinct immuno-oncology disease subcategories, thereby facilitating the discovery of biomarkers and potential drugs.
By product, consumables was the highest revenue-grossing segment in the global spatial omics technologies market in 2023 owing to the high level of use and rising launch of novel products. Additionally, instruments is predicted to grow at fastest CAGR during the forecast period owing to the growing launch of new instruments and surge in technological advancements. For instance, in September 2022, Vizgen, a life science company focused on enhancing human health through the visualization of single-cell spatial genomics data, has introduced the Protein Co-detection Kit for the MERSCOPE® Platform. This kit enables subcellular spatial multi-omics assessment by simultaneously detecting RNA and proteins in a typical MERFISH experiment.
By technology, spatial transcriptomics was the highest revenue-grossing segment in the global spatial omics technologies market in 2023 owing to the increasing advancements in sequencing technologies, surge in transcriptomic research study of single cells, rising focus on development of novel solutions for high-throughput genomic analysis, and growing partnerships & collaborations within market players. For instance, in April 2023, Bio-Techne has revealed its partnership with Lunaphore to establish an entirely automated spatial multiomics solution. Together, they will work on developing the inaugural fully automated spatial multiomics technique, allowing for the simultaneous identification of protein and RNA biomarkers on the same slide with a high degree of complexity. This new approach is anticipated to offer exceptional flexibility in panel design and streamline the process of combining antibodies with RNAscope in situ hybridization probes. Researchers will be able to use this method to accentuate differences in cell morphologies and functional states across various medical conditions. Additionally, spatial genomics is predicted to grow at fastest CAGR during the forecast period owing to the ability to investigate spatial information in biological study has improved because to the development of numerous in situ technologies. These techniques have caused the sciences of histology and embryology, which focus on structure and enable spatially detailed molecular research of biological processes, to merge with function-oriented fields of biochemistry and molecular genetics.
By workflow, instrumental analysis was the highest revenue-grossing segment in the global spatial omics technologies market in 2023 owing to the significant improvements are being made in tools such as mass spectrometry and microscopy, rising demand for mass spectrometry for calculating the amounts of proteins & nucleic acids, increasing number of benefits, including high resolution, high speed, & high throughput processes for protein profiling, surge in implement fresh applications including the creation of new drugs, the identification of biomarkers, and diagnostics. Additionally, data analysis is predicted to grow at fastest CAGR during the forecast period owing to the rising integration of advanced computational solutions for generating detailed spatial information for omics studies, growing focus on development & launch of new platforms, and increasing collaborations within major market players. For instance, in June 2023, OMAPiX has entered into strategic partnerships with Vizgen®, Inc., Resolve Biosciences, and Ultivue, Inc. Under these agreements, OMAPiX scientists will utilize Vizgen's MERSCOPE® Platform technology, Resolve Biosciences' Molecular Cartography™ technology, and Ultivue's InSituPlex® and UltiStacker® technologies. This collaboration aims to offer customers consistent, dependable, and top-quality spatial transcriptomic and proteomic data, enabling valuable insights to expedite drug development and life science research.
By end-user, academic and translational research institutes was the highest revenue-grossing segment in the global spatial omics technologies market in 2023 owing to the growing adoption of spatial OMICS in translational research, and increasing research & development activities. Additionally, pharmaceutical & biotechnology companies is predicted to grow at fastest CAGR during the forecast period owing to the rising technological advancements, surge in focus on development of advanced platforms, and increasing collaborations within market players for the launch of innovative solutions. For instance, in 2022, NanoString and Abcam have entered into a joint marketing agreement to promote Abcam antibodies for NanoString's advanced spatial multiomics solutions with high-plex capabilities.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising demand for personalized medicine, increasing prevalence of cancer, well-developed healthcare facilities, presence of novel diagnostic techniques, surge in morbidity & mortality rates due to cancer, growing need for developing novel therapies, rising partnerships & collaborations within market players. For instance, in April 2023, Canopy Biosciences, a subsidiary of Bruker Company, has partnered with Enable Medicine to integrate Enable Medicine's advanced spatial omics data processing pipelines into the Canopy CellScape technology, enabling quantitative high-plex spatial biology. This collaboration aims to improve the analytic capabilities of the CellScape system, granting users access to advanced spatial analyses offered by Enable Medicine, including cluster analysis, neighborhood analysis, and advanced data visualization. Additionally, it facilitates efficient cloud-based computing, data sharing, and storage. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in biological research activities, growing adoption of omics tools, increasing research & development activities, and rising collaborations within market players. For instance, in 2022, Illumina and AstraZeneca have revealed a strategic research partnership aimed at expediting drug target discovery. This collaboration leverages their respective capabilities in AI-based genome interpretation and genomic analysis methods, along with their industry knowledge.
Surge in partnerships among market participants is predicted to boost the market growth during the forecast period. The market's rising financing and investment efforts for the advancement of spatial omics technology are a notable trend. For instance, in June 2023, Owkin's recent announcement of securing $50 million in funding and its collaboration with NanoString Technology and academic institutions in Europe and the United States serve as prime examples of this emerging trend. Their objective is to harness spatial omics technology to advance cancer research through the MOSAIC initiative (Multi Omics Spatial Atlas in Cancer). This endeavor will entail gathering and examining 7,000 tumor samples using spatial omics methods to uncover distinct immuno-oncology disease subcategories, thereby facilitating the discovery of biomarkers and potential drugs.
By product, consumables was the highest revenue-grossing segment in the global spatial omics technologies market in 2023 owing to the high level of use and rising launch of novel products. Additionally, instruments is predicted to grow at fastest CAGR during the forecast period owing to the growing launch of new instruments and surge in technological advancements. For instance, in September 2022, Vizgen, a life science company focused on enhancing human health through the visualization of single-cell spatial genomics data, has introduced the Protein Co-detection Kit for the MERSCOPE® Platform. This kit enables subcellular spatial multi-omics assessment by simultaneously detecting RNA and proteins in a typical MERFISH experiment.
By technology, spatial transcriptomics was the highest revenue-grossing segment in the global spatial omics technologies market in 2023 owing to the increasing advancements in sequencing technologies, surge in transcriptomic research study of single cells, rising focus on development of novel solutions for high-throughput genomic analysis, and growing partnerships & collaborations within market players. For instance, in April 2023, Bio-Techne has revealed its partnership with Lunaphore to establish an entirely automated spatial multiomics solution. Together, they will work on developing the inaugural fully automated spatial multiomics technique, allowing for the simultaneous identification of protein and RNA biomarkers on the same slide with a high degree of complexity. This new approach is anticipated to offer exceptional flexibility in panel design and streamline the process of combining antibodies with RNAscope in situ hybridization probes. Researchers will be able to use this method to accentuate differences in cell morphologies and functional states across various medical conditions. Additionally, spatial genomics is predicted to grow at fastest CAGR during the forecast period owing to the ability to investigate spatial information in biological study has improved because to the development of numerous in situ technologies. These techniques have caused the sciences of histology and embryology, which focus on structure and enable spatially detailed molecular research of biological processes, to merge with function-oriented fields of biochemistry and molecular genetics.
By workflow, instrumental analysis was the highest revenue-grossing segment in the global spatial omics technologies market in 2023 owing to the significant improvements are being made in tools such as mass spectrometry and microscopy, rising demand for mass spectrometry for calculating the amounts of proteins & nucleic acids, increasing number of benefits, including high resolution, high speed, & high throughput processes for protein profiling, surge in implement fresh applications including the creation of new drugs, the identification of biomarkers, and diagnostics. Additionally, data analysis is predicted to grow at fastest CAGR during the forecast period owing to the rising integration of advanced computational solutions for generating detailed spatial information for omics studies, growing focus on development & launch of new platforms, and increasing collaborations within major market players. For instance, in June 2023, OMAPiX has entered into strategic partnerships with Vizgen®, Inc., Resolve Biosciences, and Ultivue, Inc. Under these agreements, OMAPiX scientists will utilize Vizgen's MERSCOPE® Platform technology, Resolve Biosciences' Molecular Cartography™ technology, and Ultivue's InSituPlex® and UltiStacker® technologies. This collaboration aims to offer customers consistent, dependable, and top-quality spatial transcriptomic and proteomic data, enabling valuable insights to expedite drug development and life science research.
By end-user, academic and translational research institutes was the highest revenue-grossing segment in the global spatial omics technologies market in 2023 owing to the growing adoption of spatial OMICS in translational research, and increasing research & development activities. Additionally, pharmaceutical & biotechnology companies is predicted to grow at fastest CAGR during the forecast period owing to the rising technological advancements, surge in focus on development of advanced platforms, and increasing collaborations within market players for the launch of innovative solutions. For instance, in 2022, NanoString and Abcam have entered into a joint marketing agreement to promote Abcam antibodies for NanoString's advanced spatial multiomics solutions with high-plex capabilities.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising demand for personalized medicine, increasing prevalence of cancer, well-developed healthcare facilities, presence of novel diagnostic techniques, surge in morbidity & mortality rates due to cancer, growing need for developing novel therapies, rising partnerships & collaborations within market players. For instance, in April 2023, Canopy Biosciences, a subsidiary of Bruker Company, has partnered with Enable Medicine to integrate Enable Medicine's advanced spatial omics data processing pipelines into the Canopy CellScape technology, enabling quantitative high-plex spatial biology. This collaboration aims to improve the analytic capabilities of the CellScape system, granting users access to advanced spatial analyses offered by Enable Medicine, including cluster analysis, neighborhood analysis, and advanced data visualization. Additionally, it facilitates efficient cloud-based computing, data sharing, and storage. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in biological research activities, growing adoption of omics tools, increasing research & development activities, and rising collaborations within market players. For instance, in 2022, Illumina and AstraZeneca have revealed a strategic research partnership aimed at expediting drug target discovery. This collaboration leverages their respective capabilities in AI-based genome interpretation and genomic analysis methods, along with their industry knowledge.
Segmentation: Spatial Omics Technologies Market Report 2022 - 2033
Spatial Omics Technologies Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Mn)
- Instruments
- Consumables
- Software
Spatial Omics Technologies Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Mn)
Spatial Proteomics
- Immunofluorescence Techniques
- Centrifugation Techniques
- Imaging Techniques
- Mass Spectrometry
- Others
Spatial Genomics
- FISH
- Biochemical Techniques
- Genome Perturbation Tools
- Microscopy-based Live DNA Imaging
- Massively-parallel Sequencing
- Others
Spatial Transcriptomics
- IHC
- Sequencing-based Methods
- Microscopy-based RNA Imaging Techniques
Spatial Omics Technologies Market Analysis & Forecast by Workflow 2023 - 2034 (Revenue USD Mn)
- Instrumental Analysis
- Data Analysis
- Sample Preparation
Spatial Omics Technologies Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- Pharmaceutical & Biotechnology Companies
- Academic & Translational Research Institutes
Spatial Omics Technologies Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Spatial Omics Technologies Market: Product Estimates & Trend Analysis
8. Spatial Omics Technologies Market: Technology Estimates & Trend Analysis
9. Spatial Omics Technologies Market: Workflow Estimates & Trend Analysis
10. Spatial Omics Technologies Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Spatial Omics Technologies Market
13. Europe Global Spatial Omics Technologies Market
14. Asia Pacific Global Spatial Omics Technologies Market
15. Latin America Global Spatial Omics Technologies Market
16. MEA Global Spatial Omics Technologies Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Danaher Corporation
- NanoString Technologies Inc.
- 10x Genomics
- PerkinElmer Inc.
- OMAPiX
- Seven Bridges Genomics
- Dovetail Genomics
- Standard BioTools
- S2 Genomics Inc.
- Rebus Biosystems Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 250.24 Million |
| Forecasted Market Value ( USD | $ 774.75 Million |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
